Evidence map›Paper›PMID 40681925›Full record

ArticleObesity surgery2025

Trends and Outcomes of Metabolic Surgery in Adolescents with BMI ≥ 50 vs < 50 kg/m

Pattharasai Kachornvitaya, Mélissa V Wills, Juan S Barajas-Gamboa, Salvador Navarrete, Ricard Corcelles, Andrew Strong, Suthep Udomsawaengsup, Matthew Kroh, Jerry Dang, Valentin Mocanu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pattharasai KachornvitayaDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Mélissa V WillsDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Juan S Barajas-GamboaDigestive Diseases Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Salvador NavarreteDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Ricard CorcellesDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Andrew StrongDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Suthep UdomsawaengsupDepartment of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Matthew KrohDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Jerry DangDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States.
Valentin MocanuDigestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, United States. mocanuv@ccf.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic and bariatric surgery (MBS) is an effective and increasingly utilized treatment for adolescents with severe obesity, particularly those with BMI ≥ 50 kg/m

methodsWe conducted a retrospective analysis of the MBSAQIP database from 2020-2023, identifying adolescents aged 13-18 years who underwent primary sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB). Patients were stratified by BMI into < 50 kg/m

resultsAmong 3,056 adolescents (0.4% of 692,615 total cases), 2,134 (69.8%) had BMI < 50 and 922 (30.2%) had BMI ≥ 50 kg/m

conclusionsMBS is safe in adolescents, including those with BMI ≥ 50 kg/m

Indexed as

Bariatric SurgeryGastrectomyGastric BypassObesity, MorbidPediatric ObesityAdolescentBody Mass IndexDatabases, FactualFemaleHumansMalePostoperative ComplicationsRetrospective StudiesTreatment OutcomeAdolescent obesityBMI ≥ 50 kg/m2MBSAQIP databaseRoux-en-Y gastric bypassSerious complicationsSleeve gastrectomy

Identifiers

PMID40681925
PMCPMC12457576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.